Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
mergers and acquisitions
Biotech
REGiMMUNE, Kiji merge to create Treg 'super company,' plan IPO
Taiwan’s REGiMMUNE and Europe-based Kiji are merging to create a globally minded regulatory T-cell biotech that already has its sights set on an IPO.
James Waldron
Oct 18, 2024 8:05am
Kezar rejects Concentra buyout that 'undervalues' the biotech
Oct 17, 2024 9:10am
Lundbeck signs $2.5B check for Longboard and its epilepsy med
Oct 14, 2024 8:30am
Bruker spools up spatial biology division from acquired assets
Oct 11, 2024 12:00pm
With Kezar in lupus limbo, Concentra spies potential acquisition
Oct 9, 2024 7:10am
Psyence walks away from acquisition of fellow psilocybin biotech
Oct 7, 2024 5:16am